| Drug Name: | Albendazole (54965-21-8) |
|---|---|
| PubChem ID: | 2082 |
| SMILES: | CCCSC1=CC2=C(C=C1)N=C(N2)NC(=O)OC |
| InchiKey: | HXHWSAZORRCQMX-UHFFFAOYSA-N |
| Therapeutic Category: | Anthelmintics, Anti-Infective Agents, Anticestodal Agents, Antimitotic Agents, Antiparasitic Agents, Antiplatyhelmintic Agents, Antiprotozoal Agents, Mitosis Modulators, Tubulin Modulators |
| Molecular Weight (dalton) | : | 265.338 |
| LogP | : | 3.2433 |
| Ring Count | : | 2 |
| Hydrogen Bond Acceptor Count | : | 4 |
| Hydrogen Bond Donor Count | : | 2 |
| Total Polar Surface Area | : | 67.01 |
This panel provides information on interacting drugs and their ADRs along with references
| Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
|---|---|---|---|---|
| Phenytoin (57-41-0) | Reduce Efficacy For Systemic Infections | Antagonistic | Phenytoin appear to induce the oxidative metabolism of albendazole by the cytochrome P450 isoenzyme CYP3A to roughly the same extent, resulting in significantly reduced levels of albendazole sulfoxide. | Pharmacokinetic interaction between albendazole sulfoxide enantiomers and antiepileptic drugs in patients with neurocysticercosis |
This panel provides drug-protein interaction and their ADRs along with references
| Toxicity | Interacting Protein | Mechanism | Reference |
|---|
This panel provides drug-food interactions and their ADRs along with references
| Food | Toxicity | Reference |
|---|
This panel provides information on metabolites and their ADRs along with references
| Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
|---|
This panel provides information on drug category